User profiles for LETIZIA CAVALLINI

Letizia Cavallini

IRCCS, Policlinico Sant'Orsola Malpighi
Verified email at studio.unibo.it
Cited by 62

[HTML][HTML] The prognostic power of inflammatory indices and clinical factors in metastatic castration-resistant prostate cancer patients treated with radium-223 (BIO-Ra …

…, A Gaudiano, ML Stazza, M Licari, L Cavallini… - European Journal of …, 2022 - Springer
Purpose To combine peripheral blood indices and clinical factors in a prognostic score for
metastatic castration-resistant prostate cancer (mCRPC) patients treated with radium-223 …

Le sepolture anomale in Italia: dalla lettura tafonomica all'interpretazione del gesto funerario

L Cavallini - Pagani e cristiani: forme e attestazioni di religiosità del …, 2011 - torrossa.com
Col termine “Sepolture anomale” si considerano i casi in cui l’individuo è stato sepolto in
modo diverso rispetto alle norme del periodo e/o della popolazione di cui faceva parte. Le …

Metastasis-free survival and patterns of distant metastatic disease after prostate-specific membrane antigen positron emission tomography (PSMA-PET)-guided …

…, A Farolfi, F Serani, F Medici, L Cavallini… - International Journal of …, 2022 - Elsevier
Purpose Prostate-specific membrane antigen positron emission tomography (PSMA-PET) is
increasingly used to guide salvage radiation therapy (sRT) in patients with prostate cancer …

[HTML][HTML] How smart is artificial intelligence in organs delineation? Testing a CE and FDA-approved Deep-Learning tool using multiple expert contours delineated on …

…, A Benini, S Bisello, R Cardano, L Cavallini… - Frontiers in …, 2023 - frontiersin.org
Background: A CE- and FDA-approved cloud-based Deep learning (DL)-tool for automatic
organs at risk (OARs) and clinical target volumes segmentation on computer tomography …

Stereological and functional investigations on isolated adrenocortical cells: zona fasciculata/reticularis cells of chronically ACTH-treated rats

…, P Rebuffat, AS Belloni, G Neri, L Cavallini… - Cell and tissue …, 1989 - Springer
The morphology and function of isolated inner (zona fasciculata/reticularis) adrenocortical
cells of rats pretreated with ACTH for 3, 6, 9 or 12 days were investigated. ACTH treatment …

A 13th-century cystic echinococcosis from the cemetery of the monastery of Badia Pozzeveri (Lucca, Italy)

A Fornaciari, R Gaeta, L Cavallini, G Aringhieri… - International Journal of …, 2020 - Elsevier
Objective To differentially diagnose a calcified formation recovered from a 13th century AD
grave from the Tuscan monastery of Badia Pozzeveri, Lucca, Italy. Materials A calcified …

[HTML][HTML] Further Clarification of Pain Management Complexity in Radiotherapy: Insights from Modern Statistical Approaches

…, F Fiorica, G Napoli, S Cammelli, L Cavallini… - Cancers, 2024 - mdpi.com
Simple Summary This analysis of the ARISE study, a multicenter observational cohort trial,
is based on a modern statistical approach, integrating the Least Absolute Shrinkage and …

Effects of prolonged cyclosporine-A treatment on the Leydig cells of the rat testis

L Cavallini, LK Malendowicz, G Mazzocchi, AS Belloni… - Virchows Archiv B, 1989 - Springer
The effects of a prolonged (30-day) treatment with daily therapeutical doses of cyclosporin A
(CAS) (20 mg/kg) on testicular Leydig cells were studied in adult rats. CSA administration …

[HTML][HTML] Unraveling the safety of adjuvant radiotherapy in prostate cancer: impact of older age and hypofractionated regimens on acute and late toxicity-a multicenter …

M Buwenge, G Macchia, L Cavallini, A Cortesi… - Frontiers in …, 2023 - ncbi.nlm.nih.gov
Background The objective of this study was to assess the impact of age and other patient
and treatment characteristics on toxicity in prostate cancer patients receiving adjuvant …

Simultaneous integrated radiotherapy boost to the dominant intraprostatic lesion: final results of a phase I/II trial

…, E Ippolito, G Mantini, G Siepe, L Cavallini… - Anticancer …, 2020 - ar.iiarjournals.org
Background/Aim: Late toxicity and long-term outcomes of a phase I-II trial on patients with
prostate cancer treated with an integrated boost to the dominant intraprostatic lesion (DIL) are …